SKI Market

A+| A| A-|

Indian Indices

Sensex

76,614.13 -114.24
( -0.15%)

Global Indices

Nasdaq

52,219.26 322.15
(0.62%)

Dow Jones

7,463.83 88.81
(1.20%)

Hang Seng

70,280.54 812.43
(1.17%)

Nikkei 225

10,501.14 -6.88
(-0.07%)

Forex

USD-INR

94.12 -0.28
(-0.30%)

EUR-INR

107.15 -0.14
(-0.13%)

GBP-INR

124.16 -0.32
(-0.26%)

JPY-INR

0.58 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vineet Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543298

INE505Y01010

23.0043581

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VINEETLAB

64.28

EPS(TTM)

Face Value()

Div & Yield %

Back

jaykay enterprises ltd

Gilada Finance & Investments standalone net profit rises 20.00% in the December 2025 quarter

Feb 14,2026

Net profit of Gilada Finance & Investments rose 20.00% to Rs 0.60 crore in the quarter ended December 2025 as against Rs 0.50 crore during the previous quarter ended December 2024. Sales rose 11.70% to Rs 1.91 crore in the quarter ended December 2025 as against Rs 1.71 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.91	1.71	12
OPM %	56.54	62.57	-
PBDT	0.81	0.68	19
PBT	0.80	0.67	19
NP	0.60	0.50	20

76,614.13 -114.24 ( -0.15%)

52,219.26 322.15 (0.62%)

7,463.83 88.81 (1.20%)

70,280.54 812.43 (1.17%)

10,501.14 -6.88 (-0.07%)

94.12 -0.28 (-0.30%)

107.15 -0.14 (-0.13%)

124.16 -0.32 (-0.26%)

0.58 0.00 (-0.29%)